The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans

被引:180
作者
Finlin, Brian S. [1 ,2 ]
Memetimin, Hasiyet [1 ,2 ]
Zhu, Beibei [1 ,2 ]
Confides, Amy L. [3 ,4 ]
Vekaria, Hemendra J. [5 ]
El Khouli, Riham H. [6 ]
Johnson, Zachary R. [1 ,2 ]
Westgate, Philip M. [7 ]
Chen, Jianzhong [8 ,9 ]
Morris, Andrew J. [8 ,9 ]
Sullivan, Patrick G. [5 ]
Dupont-Versteegden, Esther E. [3 ,4 ]
Kern, Philip A. [1 ,2 ]
机构
[1] Univ Kentucky, Div Endocrinol, Dept Internal Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Barnstable Brown Diabet & Obes Ctr, Coll Med, Lexington, KY 40536 USA
[3] Univ Kentucky, Dept Phys Therapy, Coll Hlth Sci, Lexington, KY 40536 USA
[4] Univ Kentucky, Ctr Muscle Biol, Lexington, KY 40536 USA
[5] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA
[6] Univ Kentucky, Dept Radiol, Coll Med, Lexington, KY 40536 USA
[7] Coll Publ Hlth, Univ Kentucky, Lexington, KY 40536 USA
[8] Univ Kentucky, Div Cardiovasc Med, Dept Internal Med, Coll Med, Lexington, KY 40536 USA
[9] Lexington Vet Affairs Med Ctr, Lexington, KY USA
关键词
BROWN ADIPOSE-TISSUE; BETA-ADRENOCEPTOR AGONISTS; MUSCLE-FIBER TYPE; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; WEIGHT-LOSS; METABOLIC HOMEOSTASIS; FAT; CELL; ADIPOCYTES;
D O I
10.1172/JCI134892
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BACKGROUND. Beige adipose tissue is associated with improved glucose homeostasis in mice. Adipose tissue contains beta 3-adrenergic receptors (beta 3-ARs), and this study was intended to determine whether the treatment of obese, insulin-resistant humans with the beta 3-AR agonist mirabegron, which stimulates beige adipose formation in subcutaneous white adipose tissue (SC WAT), would induce other beneficial changes in fat and muscle and improve metabolic homeostasis. METHODS. Before and after beta 3-AR agonist treatment, oral glucose tolerance tests and euglycemic clamps were performed, and histochemical analysis and gene expression profiling were performed on fat and muscle biopsies. PET-CT scans quantified brown adipose tissue volume and activity, and we conducted in vitro studies with primary cultures of differentiated human adipocytes and muscle. RESULTS. The clinical effects of mirabegron treatment included improved oral glucose tolerance (P < 0.01), reduced hemoglobin A1c levels (P = 0.01), and improved insulin sensitivity (P = 0.03) and beta cell function (P = 0.01). In SC WAT, mirabegron treatment stimulated lipolysis, reduced fibrotic gene expression, and increased alternatively activated macrophages. Subjects with the most SC WAT beiging showed the greatest improvement in beta cell function. In skeletal muscle, mirabegron reduced triglycerides, increased the expression of PPAR. coactivator 1 alpha (PGC1A) (P < 0.05), and increased type I fibers (P < 0.01). Conditioned media from adipocytes treated with mirabegron stimulated muscle fiber PGC1A expression in vitro (P < 0.001). CONCLUSION. Mirabegron treatment substantially improved multiple measures of glucose homeostasis in obese, insulin-resistant humans. Since beta cells and skeletal muscle do not express beta 3-ARs, these data suggest that the beiging of SC WAT by mirabegron reduces adipose tissue dysfunction, which enhances muscle oxidative capacity and improves beta cell function.
引用
收藏
页码:2319 / 2331
页数:13
相关论文
共 75 条
[1]   Challenges in beta(3)-adrenoceptor agonist drug development [J].
Arch, Jonathan R. S. .
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2011, 2 (02) :59-64
[2]   THERMOGENIC AND ANTIOBESITY ACTIVITY OF A NOVEL BETA-ADRENOCEPTOR AGONIST (BRL-26830A) IN MICE AND RATS [J].
ARCH, JRS ;
AINSWORTH, AT .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1983, 38 (04) :549-558
[3]   β3-adrenoceptor agonists:: potential, pitfalls and progress [J].
Arch, JRS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) :99-107
[4]  
ARCH JRS, 1984, INT J OBESITY, V8, P1
[5]   Regulation of Human Adipose Tissue Activation, Gallbladder Size, and Bile Acid Metabolism by a β3-Adrenergic Receptor Agonist [J].
Baskin, Alison S. ;
Linderman, Joyce D. ;
Brychta, Robert J. ;
McGehee, Suzanne ;
Anflick-Chames, Esti ;
Cero, Cheryl ;
Johnson, James W. ;
O'Mara, Alana E. ;
Fletcher, Laura A. ;
Leitner, Brooks P. ;
Duckworth, Courtney J. ;
Huang, Shan ;
Cai, Hongyi ;
Garraffo, H. Martin ;
Millo, Corina M. ;
Dieckmann, William ;
Tolstikov, Vladimir ;
Chen, Emily Y. ;
Gao, Fei ;
Narain, Niven R. ;
Kiebish, Michael A. ;
Walter, Peter J. ;
Herscovitch, Peter ;
Chen, Kong Y. ;
Cypess, Aaron M. .
DIABETES, 2018, 67 (10) :2113-2125
[6]   The evolution of β-cell dysfunction and insulin resistance in type 2 diabetes [J].
Bergman, RN ;
Finegood, DT ;
Kahn, SE .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 :35-45
[7]   Brown adipose tissue: Function and physiological significance [J].
Cannon, B ;
Nedergaard, J .
PHYSIOLOGICAL REVIEWS, 2004, 84 (01) :277-359
[8]   Circulating Levels of Resistin and Risk of Type 2 Diabetes in Men and Women: Results From Two Prospective Cohorts [J].
Chen, Brian H. ;
Song, Yiqing ;
Ding, Eric L. ;
Roberts, Christian K. ;
Manson, Joann E. ;
Rifai, Nader ;
Buring, Julie E. ;
Gaziano, J. Michael ;
Liu, Simin .
DIABETES CARE, 2009, 32 (02) :329-334
[9]   Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in Humans [J].
Chen, Kong Y. ;
Cypess, Aaron M. ;
Laughlin, Maren R. ;
Haft, Carol R. ;
Hu, Houchun Harry ;
Bredella, Miriam A. ;
Enerback, Sven ;
Kinahan, Paul E. ;
Lichtenbelt, Wouter van Marken ;
Lin, Frank I. ;
Sunderland, John J. ;
Virtanen, Kirsi A. ;
Wahl, Richard L. .
CELL METABOLISM, 2016, 24 (02) :210-222
[10]   Thermal stress induces glycolytic beige fat formation via a myogenic state [J].
Chen, Yong ;
Ikeda, Kenji ;
Yoneshiro, Takeshi ;
Scaramozza, Annarita ;
Tajima, Kazuki ;
Wang, Qiang ;
Kim, Kyeongkyu ;
Shinoda, Kosaku ;
Sponton, Carlos Henrique ;
Brown, Zachary ;
Brack, Andrew ;
Kajimura, Shingo .
NATURE, 2019, 565 (7738) :180-+